Markers of hypercoagulability and risk of death and rehospitalization in heart failure patients: a pilot study on the effects of Fondaparinux
- Registry ID
- EUCTR2008-001779-31
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE3
- Sponsor
- AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
- Start date
- 2008-05-09
- Last update
- 2026-08-16
Conditions
- heart failure patients (III-IV NYHA)
Summary
To evaluate the effects of fondaparinux on biochemical parameters and clinical events according to different duration of treatment in heart failure patients (III-IV NYHA). Primary end-point: circulating D-dimer plasma levels 2 months after enrolment
Locations
View on source registry